Aromix Topical Gel

Analgesic – Alleviation of musculoskeletal pain


In Persian Medicine, there exists records of use of compounds extracted from lavender leaves for various disorders. To evaluate the analgesic and anti-inflammatory properties of lavender, its hydro-alcoholic extract, polyphenolic compound and essential oil from its leaves were prepared and, for evaluation of its anti-inflammatory properties, writhing test for evaluation of pain induced by formalin and acetic acid for evaluation of its analgesic properties in mice and carrageenan test in rats were used. The results of this study confirmed the traditional use of lavender in treatment of painful and inflammatory diseases and recommend further studies for determining its active chemical constituents.

In another study, the analgesic properties of mint, which is considered an analgesic agent in Traditional Medicine, was studied using hot plate method in male rats. Based on the results of this study, mint distillate has analgesic properties, and its efficacy rises with a rise in the administered dose (p<0.05) in a way that the analgesic effect of mint distillate begins at the dose of 27 mg/kg and reaches a peak at 60 mg/kg. Also, the analgesic effect of mint distillate is more than aspirin (p<0.05).

To compare the effects of administration of rosemary essential oil in mouse paw edema induced by carrageenan and colitis induced by trinitrobenzenesulfonic acid (TNBS), two weeks before the test, IRC mice received, through a standard laboratory diet, rosemary essential oil in three doses (1250, 2500 and 5000 ppm). Ingestion of 5000 ppm rosemary essential oil, first aggravated the paw edema after 2 hours, but alleviated the edema in the next 24 hours.

In vitro, eucalyptus inhibits the synthesis of prostaglandin at a dose of 37μmol/l. In animal models, the anti-inflammatory and antinociceptive properties of eucalyptus have been demonstrated. In patients with dermatitis concomitant with dryness and discharge, the anti-inflammatory properties of Eucalyptus radiata has been demonstrated, which is most probably due to inhibition of inflammation markers such as TND-alpha, COX enzymes, 5-lipooxygenase and other leukotrienes, and it can be used as an alternative for topical steroids.

1,8-cineol (eucalyptol), which is the main phytoconstituent of eucalyptus, suppresses the metabolism of arachidonic acid and cytokine production in monocytes in human. In a study of the anti-inflammatory effects of 1,8-cineol, and its comparison with prednisolone in patients with steroid-related severe bronchial asthma, a 38% reduction of daily prednisolone was observed in the group receiving 1,8-cineol (in comparison to 7% in the placebo group)

3 times per day, apply a thin layer of the product to the affected area.

  • Gel
  • 75 g aluminium barrier laminate tube in cardboard box
  • Patient information leaflet inside


  • Essential oil of lavender (Lavandula angustifolia)
  • Essential oil of eucalyptus (Ecalyptus spp.)
  • Essential oil of rosemary (Rosmarinus officinalis)
  • Essential oil of peppermint (Mentha pipperita)

Active Ingredients

  • menthol, 1,8-cineol


Existence of severe allergy to the compounds in the product.


Adverse Effects

With the recommended amounts, no adverse reaction has been reported. However, mild to moderate skin allergic reactions may occur in predisposed individuals, in which case it is best to discontinue use and consult your physician.


Drug Interaction

No reported drug interaction.


Administration during Pregnancy and Lactation

Use of this product is allowed during pregnancy and lactation.(2,6) However, it is best to avoid any medication during the first trimester of the pregnancy.


Further Notes

  • Keep Aromix Topical Gel, like all other medication, away from sight and reach of children.
  • Tightly close the container right after administration.
  • Keep the medicine away from light and in 15-30°C.
  • Before using Aromix Topical Gel, apply some to the inner forearm in the proximity of your wrist. In case no sign of dermal allergy occurs within 12-24 hours, including redness, itching, burning or rash, you may begin to use Aromix Topical Gel.
  • Use disposable gloves when using Aromix Topical Gel.
  • Take extra care not to touch your eyes or other mucous membranes when applying the product.
  • After applying Aromix Topical Gel, avoid heating the area and physical exercise.
  • Avoid using the product on open wounds and damaged skin.
  • It is recommended that the time you use the product not be close to your sleeping time.
  • Pay attention to the expiration date and do not use expired products.

Keep this leaflet; you may need to read it again.

Based on presence of 0.185% menthol and 2.18% 1,8-cineol in the product.